Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Missense mutation of Fmr1 results in impaired AMPAR-mediated plasticity and socio-cognitive deficits in mice.

Tytuł:
Missense mutation of Fmr1 results in impaired AMPAR-mediated plasticity and socio-cognitive deficits in mice.
Autorzy:
Prieto M; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Folci A; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Poupon G; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Schiavi S; RomaTre University, Dept. Science, Rome, Italy.
Buzzelli V; RomaTre University, Dept. Science, Rome, Italy.
Pronot M; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
François U; University of Bordeaux, CNRS, IINS, Bordeaux, France.
Pousinha P; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Lattuada N; Università degli Studi di Milano, Dept. of Medical Biotechnology and Translational Medicine, Milan, Italy.
Abelanet S; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Castagnola S; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Chafai M; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Khayachi A; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Gwizdek C; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Brau F; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Deval E; Université Côte d'Azur, CNRS, IPMC, Valbonne, France.
Francolini M; Università degli Studi di Milano, Dept. of Medical Biotechnology and Translational Medicine, Milan, Italy.
Bardoni B; Université Côte d'Azur, Inserm, CNRS, IPMC, Valbonne, France.
Humeau Y; University of Bordeaux, CNRS, IINS, Bordeaux, France.
Trezza V; RomaTre University, Dept. Science, Rome, Italy.
Martin S; Université Côte d'Azur, Inserm, CNRS, IPMC, Valbonne, France. .
Źródło:
Nature communications [Nat Commun] 2021 Mar 10; Vol. 12 (1), pp. 1557. Date of Electronic Publication: 2021 Mar 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: [London] : Nature Pub. Group
MeSH Terms:
Cognitive Dysfunction/*genetics
Cognitive Dysfunction/*physiopathology
Fragile X Mental Retardation Protein/*metabolism
Mutation, Missense/*physiology
Receptors, Glutamate/*metabolism
Animals ; Biotinylation ; Brain/metabolism ; Brain/physiopathology ; Cells, Cultured ; Cognitive Dysfunction/metabolism ; Female ; Fragile X Mental Retardation Protein/genetics ; Hippocampus/metabolism ; Hippocampus/physiopathology ; Humans ; Immunoblotting ; Long-Term Potentiation/genetics ; Long-Term Potentiation/physiology ; Male ; Mice ; Mutation, Missense/genetics ; Patch-Clamp Techniques ; Receptors, Glutamate/genetics
References:
Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:242-55. (PMID: 24462888)
Neuron. 2013 May 22;78(4):615-22. (PMID: 23719161)
Neuron. 2011 Nov 17;72(4):630-42. (PMID: 22099464)
Neuron. 2009 Apr 30;62(2):254-68. (PMID: 19409270)
PLoS One. 2008 Apr 23;3(4):e1997. (PMID: 18431482)
Neurochem Int. 2012 Sep;61(4):517-22. (PMID: 22433907)
Eur J Neurosci. 2006 Jul;24(2):442-54. (PMID: 16903852)
J Biol Chem. 2008 Dec 26;283(52):36435-40. (PMID: 18955488)
J Neurosci. 2010 Aug 11;30(32):10624-38. (PMID: 20702695)
J Neurosci. 2007 Oct 3;27(40):10685-94. (PMID: 17913902)
Nat Neurosci. 2013 Nov;16(11):1530-6. (PMID: 23584741)
Neuron. 2001 Jan;29(1):243-54. (PMID: 11182095)
J Neurosci. 2016 Nov 9;36(45):11411-11417. (PMID: 27911743)
J Neurosci. 2014 Feb 26;34(9):3413-8. (PMID: 24573297)
Front Synaptic Neurosci. 2020 Mar 27;12:8. (PMID: 32292336)
Front Mol Neurosci. 2016 Jan 20;9:1. (PMID: 26834556)
Cereb Cortex. 1999 Oct-Nov;9(7):722-32. (PMID: 10554995)
J Neurosci Res. 2017 Jan 2;95(1-2):539-562. (PMID: 27870401)
Mol Cell. 1997 Dec;1(1):109-18. (PMID: 9659908)
Sci Transl Med. 2012 Sep 19;4(152):152ra128. (PMID: 22993295)
EMBO J. 2004 Dec 8;23(24):4749-59. (PMID: 15549132)
Science. 2020 Jun 12;368(6496):. (PMID: 32527803)
J Neurosci. 2022 Feb 23;42(8):1618-1628. (PMID: 34996816)
Horm Behav. 2015 Aug;74:53-76. (PMID: 26122289)
Neuron. 2013 Feb 20;77(4):696-711. (PMID: 23439122)
PLoS One. 2010 Mar 16;5(3):e9706. (PMID: 20300527)
Biol Psychiatry. 2012 Dec 1;72(11):924-33. (PMID: 22817866)
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15201-6. (PMID: 15475576)
Nat Genet. 1993 Jan;3(1):31-5. (PMID: 8490650)
PLoS Genet. 2009 Dec;5(12):e1000758. (PMID: 20011099)
Brain Sci. 2018 Aug 13;8(8):. (PMID: 30104506)
Semin Cell Dev Biol. 2014 Mar;27:14-22. (PMID: 24342448)
Brain Res Mol Brain Res. 2003 Oct 21;118(1-2):82-90. (PMID: 14559357)
Cereb Cortex. 2019 Jul 22;29(8):3241-3252. (PMID: 30137253)
J Pharmacol Exp Ther. 2017 Jan;360(1):48-58. (PMID: 27789681)
Mol Autism. 2015 May 13;6:24. (PMID: 25973161)
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):949-56. (PMID: 25561520)
Mol Psychiatry. 2020 Aug;25(8):1688-1703. (PMID: 31822816)
Cell Mol Life Sci. 2019 Aug;76(15):3019-3031. (PMID: 30904951)
Mol Cell Neurosci. 2006 May-Jun;32(1-2):37-48. (PMID: 16631377)
Nat Neurosci. 2011 Nov 23;14(12):1492-4. (PMID: 22119945)
Cell. 2014 May 8;157(4):869-81. (PMID: 24813610)
Nat Commun. 2018 Feb 22;9(1):757. (PMID: 29472612)
Nat Commun. 2018 Oct 15;9(1):4272. (PMID: 30323233)
Am J Med Genet A. 2018 Jan;176(1):11-18. (PMID: 29178241)
Neuropsychopharmacology. 2013 Jun;38(7):1276-86. (PMID: 23340520)
Behav Neurosci. 2008 Apr;122(2):293-300. (PMID: 18410169)
Behav Brain Res. 2015 May 15;285:105-17. (PMID: 25169255)
Annu Rev Pathol. 2012;7:219-45. (PMID: 22017584)
Neurosci Biobehav Rev. 2008 Jul;32(5):1055-70. (PMID: 18499253)
Nature. 2017 Sep 21;549(7672):384-388. (PMID: 28902836)
J Neurosci. 2013 Aug 7;33(32):13204-24. (PMID: 23926273)
Curr Biol. 2006 Feb 21;16(4):415-20. (PMID: 16488877)
Brain Res. 2006 Apr 21;1084(1):158-64. (PMID: 16574084)
Mol Autism. 2015 May 13;6:25. (PMID: 25973162)
Neurotherapeutics. 2010 Jul;7(3):264-74. (PMID: 20643379)
Hum Mol Genet. 2015 Mar 15;24(6):1733-40. (PMID: 25416280)
Am J Med Genet A. 2010 Oct;152A(10):2512-20. (PMID: 20799337)
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11591-6. (PMID: 20534533)
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10428-32. (PMID: 11517322)
Hippocampus. 2018 Sep;28(9):672-679. (PMID: 28843041)
Substance Nomenclature:
0 (Fmr1 protein, mouse)
0 (Receptors, Glutamate)
139135-51-6 (Fragile X Mental Retardation Protein)
Entry Date(s):
Date Created: 20210311 Date Completed: 20210409 Latest Revision: 20240331
Update Code:
20240331
PubMed Central ID:
PMC7946954
DOI:
10.1038/s41467-021-21820-1
PMID:
33692361
Czasopismo naukowe
Fragile X syndrome (FXS) is the most frequent form of inherited intellectual disability and the best-described monogenic cause of autism. CGG-repeat expansion in the FMR1 gene leads to FMR1 silencing, loss-of-expression of the Fragile X Mental Retardation Protein (FMRP), and is a common cause of FXS. Missense mutations in the FMR1 gene were also identified in FXS patients, including the recurrent FMRP-R138Q mutation. To investigate the mechanisms underlying FXS caused by this mutation, we generated a knock-in mouse model (Fmr1 R138Q ) expressing the FMRP-R138Q protein. We demonstrate that, in the hippocampus of the Fmr1 R138Q mice, neurons show an increased spine density associated with synaptic ultrastructural defects and increased AMPA receptor-surface expression. Combining biochemical assays, high-resolution imaging, electrophysiological recordings, and behavioural testing, we also show that the R138Q mutation results in impaired hippocampal long-term potentiation and socio-cognitive deficits in mice. These findings reveal the functional impact of the FMRP-R138Q mutation in a mouse model of FXS.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies